Money Is Long, Time Is Short

Your consummate investment is going long time and shorting money.

For those unfamiliar with terms short, and long regarding investing, here’s a primer.

Shorting a stock  involves borrowing  it from somebody else and buying it back at a reduced price thus profiting from the decline. Going long a stock is the opposite. Your profit is based on the price appreciating.

One of the premier investments you can make is spending your energy living, and not worrying about your funds so much. Time will most likely run out before your money does.

Time isn’t measured in just the amount of years you’re a sentient being on this planet. Longevity is a nuanced topic.

We aren’t talking necessarily about a longer life but a healthier one. This is called Healthspan. For most people, full health begins to decline at 65 and the remaining 14 years or so are spent in declining health.

There’s often a disconnect between health and life span.

Modern medicine can do much to keep you alive but there are no guarantees regarding your quality of life.

The decision to undergo certain life saving treatments isn’t binary

According to the WSJ, Doctors need to clearly spell out the side effects of proposed treatments so patients can make informed decisions.

Dr. Diane Meier, a palliative-care physician, will present a scenario like the following to patients to learn what matters most to them: You walk out of the office today, get hit by a car, suffer a massive brain injury and don’t improve after three months. Would you want interventions to keep you alive, or only comfort measures to relieve pain or symptoms?

How can investors go long time and short money.

One way is spending currency to keep them healthy.

Many Billionaires are going all in on this trading position.

Starting with throwing vast amounts of capital into longevity startups to the tune of $5 billion over the last 25 years.

 

These start ups are exploring fields like cellular programing which attempts to rest cells to a younger state without erasing what kind of cell they are.

Senolytics is another emerging field. Drugs are under production to clear out cells that cause inflammation and tissue damage.

Biomarkers and aging clocks are big. Using tests to measure biological age are a way for companies to speed up drug development.

AI is also a huge piece of the puzzle in the quest for the fountain of youth.

For the average Joe, there are many things you can do without relying on these moonshots. Numero Uno is realizing that there’s an excellent chance your portfolio will still be around while you are six feet under. This isn’t being morbid, it’s just the facts.

Stressing over things like the price of NVDA, while drinking excessive amounts of alcohol. eating highly processed foods and practicing poor sleep hygiene is a unprofitable trade. As you age, clinging to your money while years slip away is beyond illogical.

A large part of your investment plan should be laser focused on bridging the Healthspan-Lifespan Gap.

Source: GroWellthy

Nothing lasts forever and everyone is replaceable. Understanding your ego is the enemy and time is your most important investment is the holy grail of money management. Devoting your life to the cult of busyness never ends well.

Don’t be surprised when you play an unwinnable game, you end up losing much more than money.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.